Par Pharmaceutical Shares Surge In Pre-Market On Acquisition News

Shares of Par Pharmaceutical Companies PRX surged more than 36% in pre-market trading after the company agreed to be bought by the investment firm TPG for $50 per share in cash. The deal price represents a 37% premium over Par Pharmaceutical's closing price on Friday. Par Pharmaceutical shares jumped 36.41% to $49.90 in pre-market trading.